All In Biotech

Free tool

FAERS Monitor: Omnaris

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022004 or its brand name (Omnaris, Ciclesonide). Reports on generic versions are filed under their own applications.

Reports

4,999

Serious

4,577

92% of reports

Hospitalization

2,249

Death reported

264

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • asthma1,876
  • dyspnoea1,500
  • wheezing1,439
  • therapeutic product effect incomplete1,057
  • obstructive airways disorder851
  • productive cough759
  • cough740
  • condition aggravated682
  • pneumonia654
  • full blood count abnormal614
  • drug ineffective596
  • sleep disorder due to a general medical condition588
  • loss of personal independence in daily activities533
  • off label use474
  • chest discomfort467

Reports by year received

View as table
YearReports
20062
20073
200811
200943
201074
201168
2012112
201388
201499
2015157
2016237
2017186
2018220
2019435
2020609
2021728
2022459
2023355
2024426
2025391
2026296

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,160 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
obstructive airways disorderSignal851348.5326.9272,182
full blood count abnormalSignal614259.2240.1148,588
sleep disorder due to a general medical conditionSignal588150.9139.684,428
wheezingSignal1,439104.6100.1144,392
asthmaSignal1,87671.068.5127,948
productive coughSignal75968.063.649,329
therapeutic product effect incompleteSignal1,05763.460.164,154
loss of personal independence in daily activitiesSignal53347.243.523,844
chest discomfortSignal46719.317.78,074
dyspnoeaSignal1,50011.210.714,234
coughSignal74011.110.46,886
condition aggravatedSignal6829.58.85,213
pneumoniaSignal6548.57.94,388
off label useSignal4742.32.1353
drug ineffective5961.91.8271

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.